White Sandra K, Walker Brandon S, Potter Scott, Anderson David, Metcalf Ryan A
Department of Pathology, University of Utah, Salt Lake City, Utah, USA.
ARUP Laboratories, Salt Lake City, Utah, USA.
Transfusion. 2025 Jun;65(6):1061-1071. doi: 10.1111/trf.18258. Epub 2025 May 7.
Transfusion-associated circulatory overload (TACO) is an adverse event that is the leading cause of transfusion-related death. It is underrecognized, and the aim of this study was to synthesize the available evidence from active surveillance studies to estimate its incidence.
This study is a systematic review and meta-analysis of publications reporting TACO incidence using active surveillance. A research librarian searched Medline and Embase, identifying publications between January 1991 and June 2024. Studies reporting TACO either by patient, blood component (red blood cells [RBCs], platelets, or plasma) or transfusion episode were identified, and all patient settings were eligible. A random effects model estimated TACO incidence, and potential sources of heterogeneity were evaluated using meta-regression.
Twenty-two studies met eligibility criteria and were included for analysis. The rate per patient was 22.2/1000 (95% CI: 16.2-29.2) based on 21 studies. The rate estimate of TACO among total blood components (RBCs, plasma, and platelets combined) reported in 10 studies was 2.2/1000 units transfused (95% CI: 1.2-3.5/1000). There was substantial between-study variation in rates and more recent studies tended to report higher rates. Although the platelet point estimate was higher than the point estimates for RBCs and plasma, the confidence intervals overlapped. Only two studies reported TACO rates per transfusion episode and the pooled estimate was 6.3/1000 (95% CI: 1-16.3/1000), about three times greater than the overall per unit estimate.
Clinicians should consider quantitative risks of important transfusion-related harms, such as TACO, when making the decision to transfuse.
输血相关循环超负荷(TACO)是一种不良事件,是输血相关死亡的主要原因。它未得到充分认识,本研究的目的是综合主动监测研究中的现有证据来估计其发生率。
本研究是对报告TACO发生率的主动监测出版物进行系统评价和荟萃分析。一名研究馆员检索了Medline和Embase,确定了1991年1月至2024年6月期间的出版物。纳入了按患者、血液成分(红细胞[RBC]、血小板或血浆)或输血事件报告TACO的研究,所有患者情况均符合条件。采用随机效应模型估计TACO发生率,并使用荟萃回归评估异质性的潜在来源。
22项研究符合纳入标准并纳入分析。基于21项研究,每位患者的发生率为22.2/1000(95%CI:16.2 - 29.2)。10项研究报告的全血成分(红细胞、血浆和血小板合计)中TACO的发生率估计为每输注1000单位2.2/1000(95%CI:1.2 - 3.5/1000)。研究间的发生率存在很大差异,较新的研究往往报告更高的发生率。虽然血小板的点估计高于红细胞和血浆的点估计,但置信区间有重叠。只有两项研究报告了每次输血事件的TACO发生率,合并估计值为6.3/1000(95%CI:1 - 16.3/1000),约为总体每单位估计值的三倍。
临床医生在做出输血决定时应考虑重要输血相关危害(如TACO)的定量风险。